Siplizumab selectively depletes effector memory T cells and promotes a relative expansion of alloreactive regulatory T cells in vitro
Open Access
- 18 July 2019
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (1) , 88-100
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (S10RR027050, S10OD020056, P30CA013696, 5P30DK063608)
This publication has 44 references indexed in Scilit:
- Anti-thymocyte globulin (ATG) differentially depletes naïve and memory T cells and permits memory-type regulatory T cells in nonobese diabetic miceBMC Immunology, 2012
- Mechanisms of Donor-Specific Tolerance in Recipients of Haploidentical Combined Bone Marrow/Kidney TransplantationAmerican Journal of Transplantation, 2011
- Selective Targeting of Human Alloresponsive CD8+ Effector Memory T Cells Based on CD2 ExpressionAmerican Journal of Transplantation, 2010
- Homeostatic Expansion and Phenotypic Conversion of Human T Cells Depend on Peripheral Interactions with APCsThe Journal of Immunology, 2010
- Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor functionJournal of Translational Medicine, 2009
- Contribution of Naïve and Memory T-Cell Populations to the Human Alloimmune ResponseAmerican Journal of Transplantation, 2009
- Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primatesNature Medicine, 2009
- FOXP3 Promoter Demethylation Reveals the Committed Treg Population in HumansPLOS ONE, 2008
- HLA-Mismatched Renal Transplantation without Maintenance ImmunosuppressionNew England Journal of Medicine, 2008
- Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabineExperimental Hematology, 2007